Search results
Results from the WOW.Com Content Network
Cencora, Inc., formerly known as AmerisourceBergen, is an American drug wholesale company and a contract research organization that was formed by the merger of Bergen Brunswig and AmeriSource in 2001.
Steven H. Collis (born 1961) is an American businessman, the chairman, president and chief executive officer (CEO) of Cencora, previously known as AmerisourceBergen.
Let's see if AmerisourceBergen Corporation (ABC) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
File:AmerisourceBergen logo.svg. Size of this PNG preview of this SVG file: 800 × 218 pixels. Other resolutions: 320 × 87 pixels | 640 × 174 pixels | 1,024 × 279 pixels | 1,280 × 349 pixels | 2,560 × 698 pixels. Original file (SVG file, nominally 1,024 × 279 pixels, file size: 14 KB) This is a file from the Wikimedia Commons.
Is AmerisourceBergen (ABC) a great pick from the value investor's perspective right now? Read on to know more.
AmerisourceBergen's (ABC) fiscal fourth-quarter results are likely to be driven by its core Pharmaceutical Distribution business despite a competitive industry.
AmerisourceBergen (ABC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.